Incyte Corporation (INCY) Stock by the Numbers

Incyte Corporation (INCY) receives a strong valuation ranking of 88 from InvestorsObserver data analysis. The proprietary ranking system focuses on the underlying health of a company through analysis of its stock price, earnings, and growth rate. INCY has a better value than 88% of stocks based on these valuation analytics. Investors primarily focused on buy-and-hold strategies will find the valuation ranking relevant to their goals when making investment decisions.

INCY gets a 88 Valuation Rank today. Find out what this means to you and get the rest of the rankings on INCY!

See Full INCY Report

Metrics Analysis

INCY's trailing-12-month Price to Earnings (PE) ratio of 43.8 puts it above the historical average of roughly 15. INCY is a poor value at its current trading price as investors are paying more than what its worth in relation to the company's earnings. INCY's trailing-12-month earnings per share (EPS) of 1.53 does not justify what it is currently trading at in the market. Trailing PE ratios, however, do not factor in a company's projected growth rate, resulting in some firms having high PE ratios due to high growth potentially enticing investors even if current earnings are low. INCY has a 12 month forward PE to Growth (PEG) ratio of 0.81. Markets are overvaluing INCY in relation to its projected growth as its PEG ratio is currently above the fair market value of 1. 1.52999997's PEG comes from its forward price to earnings ratio being divided by its growth rate. PEG ratios are one of the most used valuation metrics due to its incorporation of more company fundamentals metrics and a focus on the firm's future rather than its past.

Summary

All together these valuation metrics paint a pretty adequate picture for INCY at its current price due to a fairly valued PEG ratio despite strong growth. The PE and PEG for INCY are around the average of the market resulting in a valuation score of 88. Click Here to get the full Report on Incyte Corporation (INCY) stock.